Public trading strategy
Vertex drops $10B to dominate hormone treatments — ride the acquisition momentum
Thesis
Big acquisitions in the biotech space often signal that the acquiring company is confident in its future growth and sees strong value in the target's research. If the market reacts positively and pushes the acquiring company's stock up, it shows investor approval of the deal. This momentum often continues as the market prices in the new combined potential of the two companies.
Strategy approach
Build an event-driven strategy that enters long VRTX on D1 if the stock closes within 2% of its pre-announcement price (or higher) within 5 days of the M&A news. Exit if the stock drops 5% from the entry point or after a 30-day hold.
Markets and timeframes
VRTXD1